One moment, please...
immunogenesis.com
Actively hiring
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$50.2M
2 rounds on record
Latest round
$5.7M
Venture round · Dec 2024 · 21 mo ago
Team
51-200
employees, estimated range
The money's age
Due for its next round
21 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 18, 2024
Raised a round Venture round $5.7M · SEC Form D
Mar 18, 2024
Raised a round Venture round $44.4M · SEC Form D
2019
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2024 | $5.7M | — | SEC Form D |
| Venture round | Mar 2024 | $44.4M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | ImmunoGenesis, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
James BarlowExecutive Officer, DirectorSEC Form D
Jeremy BartonExecutive OfficerSEC Form D
Federica O'BrienExecutive OfficerSEC Form D
Federica PericleExecutive OfficerSEC Form D
Jennifer BarlowExecutive Officer, DirectorSEC Form D
People
James Barlow
Executive Officer, Director
Jeremy Barton
Executive Officer
Federica O'Brien
Executive Officer
Federica Pericle
Executive Officer
Jennifer Barlow
Executive Officer, Director
Michael Curran
Director
Thomas Barton
Director
Robert Stein
Director
Ted Koutouzis
Director
Clifford Stocks
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Houston
United States
HQ
50-200 est. staff